CTOs on the Move

RedHill Biopharma

www.redhillbio.com

 
RedHill Biopharma, established in 2009, is a publicly traded (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) specialty biopharmaceutical company, headquartered in Israel, primarily focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for the treatment of gastrointestinal and inflammatory diseases, including cancer. RedHill’s pipeline includes several drug candidates in advanced clinical development stages addressing clear medical needs and aiming to relieve suffering and save lives. RedHill’s drugs are largely de-risked and are potentially of lower cost and faster to market than new chemical entities under development. RedHill’s products are based on several technology platforms and address several disease ...
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.redhillbio.com
  • 8045 Arco Corporate Drive Suite 120
    Raleigh, NC USA 27617
  • Phone: +972 3.541.3131

Executives

Name Title Contact Details
Rick Scruggs
Chief Operating Officer Profile
Serge Zwikker
Director of Information Technology Profile

Similar Companies

Gate Pharmaceuticals

Gate Pharmaceuticals is a North Wales, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

International Medication Systems

International Medication Systems is a South El Monte, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Chartiers Center

Chartiers’ primary focus is the integration of physical health and mental health wellness to enhance the quality of life for all people with behavioral or intellectual/ and developmental disabilities. Chartiers operates programs for adults with inte...

Navidea

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) is a biopharmaceutical company focused on the development of precision immunodiagnostic agents and immunotherapeutics. Navidea is developing multiple precision-targeted products based on its Manocept™ platform to enhance patient care by identifying the sites and pathways of disease and enable better diagnostic accuracy, clinical decision-making, and targeted treatment. Navidea`s Manocept platform is predicated on the ability to specifically target the CD206 mannose receptor expressed on activated macrophages. The Manocept platform serves as the molecular backbone of Tc99m tilmanocept, the first product developed and commercialized by Navidea based on the platform. Navidea`s strategy is to deliver superior growth and shareholder return by bringing to market novel products and advancing the Company`s pipeline through global partnering and commercialization efforts.

JHP Pharmaceutical

JHP Pharmaceutical is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.